JANSSEN-CILAG A/S: Financial statements 2021
CVR: 19248615
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
JANSSEN-CILAG A/S (CVR 19248615) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 1,317,424,000 and a net result of DKK 60,581,000 compared with DKK 56,374,000 the year before. That is an increase of 1% compared with the year before. The profit margin was 4.6%. Equity in the 2021 report amounted to DKK 134,962,000. The solvency ratio was 30.9%. The company had 142 employees in the financial year.
- Revenue
- DKK 1,317,424,000
- Gross Profit
- DKK 286,083,000
- Profit/Loss
- DKK 60,581,000
- Equity
- DKK 134,962,000
- Total Assets
- DKK 436,161,000
- Employees
- 142
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 1.3B | 286.1M | 60.6M | 135M | 142 |
| 2020 | 1.3B | 270.4M | 56.4M | 132.8M | 116 |
| 2019 | 1.2B | 273.7M | 54.8M | 126.4M | 115 |
| 2018 | 1.2B | 275.1M | 60.5M | 375.4M | 106 |
| 2017 | 968.1M | 236.1M | 37.1M | 314.9M | 116 |
Official annual report
Find more companies like JANSSEN-CILAG A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
JANSSEN-CILAG A/S has published its annual report for 2020. Revenue came to DKK 1,304,814,000, and the net result was DKK 56,374,000.
About JANSSEN-CILAG A/S
JANSSEN-CILAG A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 1969. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named JANSSENPHARMA A/S. The management consists of Mario Klesse. The board consists of Philipp Christian Hellweg (chair), Liana Akhmetzhanova, Mario Klesse and Nevret Mahmudovski. The company is owned by Janssen Cilag AB. The company has 116 employees (2026). In 2025, the company reported revenue of DKK 1,442,304,000 and a net result of DKK 43,183,000 compared with DKK 64,466,000 the year before. Equity in the 2025 report amounted to DKK 216,425,000.